Hemoperfusion as an Adjuvant Therapy in Maintenance Hemodialysis Patients with Severe COVID-19: A Single Centre Experience
Ma J, Xia P, Zhou Y, et al. Potential effect of blood purification therapy in reducing cytokine storm as a late complication in critically ill COVID-19. Clin Immunol. 2020;214:108408.
Ronco C, Reis T, de Rosa S. Coronavirus epidemic and extracorporeal therapies in intensive care: Si vis pacem para bellum. Blood Purif. 2020;49:255–8.
Ronco C, Bagshaw SM, Bellomo R, et al. Extracorporeal blood purification and organ support in the critically ill patient during covid-19 pandemic: expert review and recommendation. Blood Purif. 2020;1–11. doi:10.1159/000508125.
Ragab D, Eldin S, Taeimah M, et al. The COVID-19 cytokine storm; What we know so far. Front Immunol. 2020;11:1–4.
Safari S, Salimi A, Zali A, et al. Extracorporeal hemoperfusion as a potential therapeutic option for severe COVID-19 patients: a narrative review. Arch Acad Emerg Med. 2020;8:e67.
Winchester J. Dialysis techniques: hemoperfusion. Replacement of renal function by dialysis. In: Horl W H, Koch K, Lindsay R, Ronco C, Winchester J. Springer; 2004. p. 725–38.
Huang Z, Wang SR, Yang Z, et al. Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2013;17:454–61.
Huang Z, WangSR, Su W, et al. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2010;14:596–602.
Sun S, He L, Bai M, et al. High-volume hemofltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: A controlled pilot study. Ann Saudi Med. 2015;35:352–8.
Ranieri VM. Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012;307:2526–33.
Asgharpour M. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19). BMC Nephrol. 2020;21.
Vardanjani EA. Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19. Blood Purif. 2020; 3848176941:8–11.
Du Y, Qi Z, Ma J, et al. Case report: A patient with COVID-19 who benefited from hemoadsorption. Front Med. 2020;7:1–5.
Mezger M. Sequential use of hemadsorption using Cytosorb® and Biosky® filter-technology in a COVID-19 patient suffering from severe ARDS. Arch Clin Med Case Reports. 2020;04:969–77.
Moradi H, Abbasi S. Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: A case report. Int Med Case Rep J. 2020;13:341–5.
Shadvar K, Tagizadiyeh A, Gamari AA, et al. Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm. Blood Purif. 2020;5157663314.
Ankawi G, Fan W, Montin DP. et al. A new series of sorbent devices for multiple clinical purposes: Current evidence and future directions. Blood Purif. 2019;47: 94–100.
Hajian S, Rastgoo N. The effect of hemoperfusion on the recovery of COVID-19 in hospitalized patients; case series and review study. 2021;7:4–7.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.